Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections

Roche announced today the CE-IVD launch of the cobas ® MRSA/SA nucleic acid test for use on the cobas® Liat® System for the qualitative detection and differentiation of methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) at the point of care. MRSA and SA are both major sources of healthcare and community associated inf ections.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news